thiophene-2-carboxylate has been researched along with telaprevir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartenschlager, R; Cecchetti, V; Coelmont, L; Easmon, J; Herdewijn, P; Leyssen, P; Mittendorfer, H; Neyts, J; Paeshuyse, J; Puerstinger, G; Tabarrini, O; Vliegen, I | 1 |
| Cammack, N; Kular, S; McCown, MF; Nájera, I; Rajyaguru, S | 1 |
2 other study(ies) available for thiophene-2-carboxylate and telaprevir
| Article | Year |
|---|---|
Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.
Topics: Antiviral Agents; Cell Line, Tumor; DNA Helicases; Enzyme Inhibitors; Hepacivirus; Humans; Microbial Sensitivity Tests; Protease Inhibitors; Replicon; RNA-Dependent RNA Polymerase; Virus Replication | 2008 |
GT-1a or GT-1b subtype-specific resistance profiles for hepatitis C virus inhibitors telaprevir and HCV-796.
Topics: Antiviral Agents; Benzofurans; Drug Resistance, Viral; Genotype; Hepacivirus; Humans; Kinetics; Microbial Sensitivity Tests; Oligopeptides; Protease Inhibitors; Sulfonamides; Viral Nonstructural Proteins; Virus Replication | 2009 |